Literature DB >> 14749936

Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension.

A F Folino1, F Bobbo, C Schiraldi, F Tona, S Romano, G Buja, F Bellotto.   

Abstract

The aim of our study was to assess the arrhythmic profile in patients with primary pulmonary hypertension (PPH) and its correlation with autonomic features, echocardiographic indexes and pulmonary function. We studied 9 subjects with a mean age of 42 +/- 11 years. All underwent echocardiography, 24-hour Holter monitoring, and cardiopulmonary exercise testing. Left ventricle ejection fraction was normal (65 +/- 6%). The right ventricle end diastolic volume was increased (108 +/- 32 ml/m2) with a slight reduction of ejection fraction (49 +/- 5%). Right ventricle systolic pressure was increased (91 +/- 25 mmHg). Heart rate variability analysis showed evidence of a reduced standard deviation of all NN intervals (SDNN) compared with the control group (102.8 +/- 32 versus 156.1 +/- 32, p < 0.005). Patients with significant ventricular arrhythmias had a lower SDNN, and lower baseline and effort PO2 (SDNN: 87.0 +/- 15 versus 115.4 +/- 38; baseline PO2: 63.2 +/- 12% versus 78.8 +/- 7%; effort PO2: 50.7 +/- 13% versus 68.7 +/- 19%). The patients with SDNN lower than 90 ms were characterized by a higher right ventricle systolic pressure (115.0 +/- 22.9 mmHg versus 79.2 +/- 17.8 mmHg, p = 0.035). The patients who experienced syncope had higher SDNN (131.7 +/- 36 versus 88.4 +/- 20, p < 0.05), higher effort PO2 (77.5 +/- 14 mmHg versus 52.3 +/- 14 mmHg, p < 0.03). The patients with PPH evidenced an increased sympathetic activity. Premature ventricular beats were more frequent in those subjects with higher adrenergic drive and lower oxygen saturation. Patients with episodes of syncope seem to have a relatively higher vagal activity, and effective mechanisms of adjustment in blood oxygenation during effort.

Entities:  

Mesh:

Year:  2003        PMID: 14749936     DOI: 10.1007/s00408-003-1034-x

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  22 in total

1.  Heart rate variability in patients with vasovagal syndrome.

Authors:  G N Theodorakis; D T Kremastinos; G T Avrambos; G S Stefanakis; G K Karavolias; P K Toutouzas
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

Review 2.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

3.  Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.

Authors:  P Schenk; V Petkov; C Madl; L Kramer; M Kneussl; R Ziesche; I Lang
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

4.  Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Authors:  H Wilkens; A Guth; J König; N Forestier; B Cremers; B Hennen; M Böhm; G W Sybrecht
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

5.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

Review 6.  Primary pulmonary hypertension.

Authors:  L J Rubin
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

7.  24-hour heart rate variability in patients with vasovagal syncope.

Authors:  C Lazzeri; G La Villa; G Barletta; F Franchi
Journal:  Pacing Clin Electrophysiol       Date:  2000-04       Impact factor: 1.976

8.  Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.

Authors:  V Petkov; R Ziesche; W Mosgoeller; P Schenk; K Vonbank; L Stiebellehner; M Raderer; C Brunner; M Kneussl; L H Block
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

10.  [Cardiac arrhythmia in patients with chronic obstructive lung disease and therapy].

Authors:  A K Klitzke; C P Criee; K P Bethge; D Bethge; G Laier-Groeneveld; U Hüttemann
Journal:  Pneumologie       Date:  1990-02
View more
  22 in total

1.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical study.

Authors:  Dirk Bandorski; D Erkapic; J Stempfl; R Höltgen; E Grünig; J Schmitt; R Chasan; J Grimminger; T Neumann; C W Hamm; W Seeger; H A Ghofrani; H Gall
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-02

3.  Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity.

Authors:  Debbie Friedman; Jacqueline Szmuszkovicz; Miklos Rabai; Jon A Detterich; Jondavid Menteer; John C Wood
Journal:  J Heart Lung Transplant       Date:  2012-03-21       Impact factor: 10.247

Review 4.  [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].

Authors:  Dirk Bandorski; Reinhard Höltgen; Ardeschir Ghofrani; Viktoria Johnson; Jörn Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

5.  Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence.

Authors:  Piotr Bienias; Maciej Kostrubiec; Zuzanna Rymarczyk; Dariusz Korczak; Michał Ciurzyński; Marcin Kurzyna; Adam Torbicki; Anna Fijałkowska; Piotr Pruszczyk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-05       Impact factor: 1.468

Review 6.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

7.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

8.  Incidence, predictors, and clinical course of atrial tachyarrhythmias in patients with pulmonary hypertension.

Authors:  Arun Kanmanthareddy; Yeruva Madhu Reddy; Hemant Boolani; Sowjanya Duthuluru; Jayasree Pillarisetti; Ajay Vallakati; Sudharani Bommana; Donita Atkins; Timothy Williamson; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2014-07-09       Impact factor: 1.900

9.  Diminazene aceturate improves autonomic modulation in pulmonary hypertension.

Authors:  Katya Rigatto; Karina R Casali; Vinayak Shenoy; Michael J Katovich; Mohan K Raizada
Journal:  Eur J Pharmacol       Date:  2013-05-09       Impact factor: 4.432

10.  Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.

Authors:  Philip L Mar; Victor Nwazue; Bonnie K Black; Italo Biaggioni; André Diedrich; Sachin Y Paranjape; James E Loyd; Anna R Hemnes; Ivan M Robbins; David Robertson; Satish R Raj; Eric D Austin
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.